Homepage
Learn about promising cancer treatments and donate to a cancer research charity to help with efforts to make every cancer patient a survivor.
Learn about promising cancer treatments and donate to a cancer research charity to help with efforts to make every cancer patient a survivor.
Samilia Obeng-Gyasi, MD, MPH, expands on the impact of social determinants of health on breast cancer care.
Dry, scaly skin can be a sign of many common dermatologic issues, and sometimes even a sign of cancer. We checked with dermatologist Saira George,…
Supported by an independent educational grant from Genmab US, Inc. and AbbVie This live roundtable discussion will center on the advancing field of bispecific antibodies…
In case you missed it, below is your guide to the important regulatory approvals made by the FDA in April 2024.
In a Chinese phase III trial, researchers found that neither capecitabine nor XELOX (capecitabine, oxaliplatin) improved 2-year overall survival vs cisplatin/fluorouracil as part of definitive…
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
Brain and Other Nervous System Cancer statistics
Jean L. Koff, MD, MS, highlights data for pirtobrutinib in pretreated CLL/SLL and how the agent altered later-line care for these patients.
Halle Moore, MD, discusses some of the main concerns that patients with breast cancer have about fertility after treatment.
HRR testing is underused in patients with metastatic castration-resistant prostate cancer, a large study suggests.